Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TKCell and FOLFOX-4 in Advanced Colorectal Cancer
NCT00854971Phase 2Unknown
- Sponsor
- Binex Co., Ltd.
- Start
- Jan 2009
- Primary completion
- Jan 2010
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of TKCell in colorectal cancer (CRC) (2 arms), sponsored by Binex Co., Ltd. Primary endpoint: Response Rate. Status: unknown.
02
Drugs
TKCell
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00854971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854971.